You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acute promyelocytic leukemia (M3)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

    Recruiting
    • Newly-diagnosed APL (de Novo or Therapy-related)
    • Relapsed APL
    • observational
    • Dresden, Germany
      Prof. Dr. U. Platzbecker
    Aug 10, 2022

    Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

    Recruiting
    • Acute Promyelocytic Leukemia
    • +2 more
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Apr 26, 2023

    APL Trial in Shanghai (Chidamide+venetoclax)

    Active, not recruiting
    • APL
    • Shanghai, Shanghai, China
      Jiong HU
    May 30, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

    Active, not recruiting
    Has Results
    • Childhood Acute Promyelocytic Leukemia (M3)
    • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    • arsenic trioxide
    • +7 more
    • Birmingham, Alabama
    • +110 more
    Mar 23, 2022

    Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Birmingham, Alabama
    • +4 more
    Jul 12, 2022

    Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

    Recruiting
    • Promyelocytic Leukemia
    • Arsenic trioxide
    • all-trans retinoic acid
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Aug 9, 2022

    Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Realgar-Indigo naturalis formula
    • +3 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 31, 2021

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Leukemia Trial in Tianjin (DNR:, Ara-c)

    Completed
    Has Results
    • Leukemia
    • Tianjin, Tianjin, China
    • +1 more
    Aug 8, 2021

    RWE of 1st Line Treatment With ATO/ATRA for Adult APL

    Recruiting
    • Promyelocytic Leukemia, Adult Acute
    • Evaluation of first line treatment with ATO/ATRA outcome
    • Caba, Argentina
    • +1 more
    Nov 9, 2021

    Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

    Completed
    Has Results
    • Acute Promyelocytic Leukemia
    • Tretinoin and Arsenic Trioxide
    • Los Angeles, California
    • +11 more
    Nov 2, 2021

    Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +5 more
    • Innsbruck, Austria
    • +109 more
    Oct 10, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Brussels, Belgium
    • +30 more
    Aug 9, 2022

    Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • cladribine + homoharringtonine + cytarabine
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Jun 13, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

    Completed
    • Leukemia, Acute
      • (no location specified)
      Jul 23, 2023

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

      Not yet recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
      • Hefei, Anhui, China
      • +7 more
      Jun 27, 2023

      Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

      Recruiting
      • Acute Myeloid Leukemia in Remission
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 13, 2022

      Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

      Terminated
      • Adult Acute Basophilic Leukemia
      • +16 more
      • eltrombopag olamine
      • standard follow-up care
      • Atlanta, Georgia
      • +1 more
      Jul 20, 2022